KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $399,797 | -55.6% | 223,350 | -3.5% | 0.00% | -100.0% |
| Q1 2023 | $900,730 | +2.2% | 231,550 | -10.7% | 0.00% | 0.0% |
| Q4 2022 | $881,110 | -4.7% | 259,150 | +52.9% | 0.00% | 0.0% |
| Q3 2022 | $925,000 | +27.6% | 169,450 | +5.4% | 0.00% | – |
| Q2 2022 | $725,000 | -38.8% | 160,750 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $1,185,000 | +23.3% | 160,750 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $961,000 | +25.5% | 149,450 | +13.5% | 0.00% | – |
| Q3 2021 | $766,000 | -43.6% | 131,650 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,359,000 | +9.7% | 131,650 | +11.8% | 0.00% | 0.0% |
| Q1 2021 | $1,239,000 | -31.0% | 117,750 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $1,796,000 | +6.0% | 116,050 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,694,000 | -12.7% | 116,050 | +13.3% | 0.00% | -50.0% |
| Q2 2020 | $1,940,000 | +3.6% | 102,450 | +5.1% | 0.00% | 0.0% |
| Q1 2020 | $1,872,000 | +3.1% | 97,450 | +2.8% | 0.00% | 0.0% |
| Q4 2019 | $1,816,000 | +108.5% | 94,750 | +4.6% | 0.00% | +100.0% |
| Q3 2019 | $871,000 | +60.7% | 90,550 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $542,000 | +9.1% | 90,550 | +6.3% | 0.00% | 0.0% |
| Q1 2019 | $497,000 | -37.7% | 85,150 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $798,000 | -45.0% | 85,150 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,450,000 | +0.2% | 85,150 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,447,000 | +68.1% | 85,150 | +32.7% | 0.00% | +100.0% |
| Q1 2018 | $861,000 | +57.7% | 64,150 | +12.8% | 0.00% | 0.0% |
| Q4 2017 | $546,000 | -12.5% | 56,850 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $624,000 | +21.4% | 56,850 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $514,000 | -2.1% | 56,850 | +39.2% | 0.00% | 0.0% |
| Q1 2017 | $525,000 | +51.7% | 40,850 | +10.9% | 0.00% | 0.0% |
| Q4 2016 | $346,000 | -3.6% | 36,850 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $359,000 | +45.3% | 36,850 | 0.0% | 0.00% | – |
| Q2 2016 | $247,000 | -16.6% | 36,850 | +7.3% | 0.00% | -100.0% |
| Q1 2016 | $296,000 | -20.0% | 34,350 | +23.1% | 0.00% | 0.0% |
| Q4 2015 | $370,000 | +25.9% | 27,900 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $294,000 | -58.3% | 27,900 | +7.7% | 0.00% | -50.0% |
| Q2 2015 | $705,000 | -3.7% | 25,900 | +8.4% | 0.00% | 0.0% |
| Q1 2015 | $732,000 | -0.3% | 23,900 | +21.9% | 0.00% | -33.3% |
| Q4 2014 | $734,000 | +7.2% | 19,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $685,000 | +19.5% | 19,600 | +59.3% | 0.00% | +50.0% |
| Q2 2014 | $573,000 | – | 12,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |